Alector, Inc. ALEC NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

41/100

2/7 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Alector, Inc. (ALEC), dont 20 achats et 28 ventes. Le total des achats d'initiés s'élève à $1.23M et le total des ventes d'initiés à $1.32M.

Les initiés notables ayant une activité récente comprennent Berkley Neil Lindsay, Rosenthal Arnon, Wong-sarad Grace. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ALEC

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-15	Berkley Neil Lindsay	CFO & Chief Business Officer	Attribution de RSU	54,600	-	-	399,260
2026-03-13	Rosenthal Arnon	Chief Executive Officer	Attribution de RSU	116,246	-	-	2,454,422
2026-03-10	Wong-sarad Grace	Principal Accounting Officer	Vente Informative	1,000	$2.65	$2.65K	106,465
2026-03-03	Wong-sarad Grace	Principal Accounting Officer	Vente Informative	3,367	$2.08	$7.01K	107,465
2026-03-02	Rosenthal Arnon	Chief Executive Officer	Vente Informative	81,864	$2.12	$173.82K	2,338,176
2026-03-02	Wong-sarad Grace	Principal Accounting Officer	Vente Informative	8,071	$2.12	$17.14K	110,832
2026-03-02	Berkley Neil Lindsay	CFO & Chief Business Officer	Vente Informative	29,649	$2.12	$62.95K	344,660
2026-02-26	Wong-sarad Grace	Principal Accounting Officer	Vente Informative	4,079	$2.50	$10.2K	118,903
2025-12-05	Wong-sarad Grace	Principal Accounting Officer	Vente Informative	4,753	$1.21	$5.75K	122,982
2025-12-03	Rosenthal Arnon	Chief Executive Officer	Vente Informative	104,347	$1.12	$116.83K	2,420,040
2025-12-03	Kenkare-mitra Sara	President and Head of R&d	Vente Informative	41,687	$1.12	$46.67K	501,652
2025-12-03	Wong-sarad Grace	Principal Accounting Officer	Vente Informative	8,056	$1.12	$9.02K	127,735
2025-12-03	Berkley Neil Lindsay	Chief Bus Ofcr & Interim CFO	Vente Informative	37,261	$1.12	$41.72K	374,309
2025-11-10	Rosenthal Arnon	Chief Executive Officer	Attribution de RSU	522,500	$1.31	$684.48K	522,500
2025-11-10	Wong-sarad Grace	Principal Accounting Officer	Attribution de RSU	48,535	$1.31	$63.58K	48,535
2025-11-10	Berkley Neil Lindsay	Chief Bus Ofcr & Interim CFO	Attribution de RSU	195,000	$1.31	$255.45K	195,000
2025-09-02	Rosenthal Arnon	Chief Executive Officer	Vente Informative	51,562	$2.50	$128.74K	2,350,220
2025-09-02	Kenkare-mitra Sara	President and Head of R&d	Vente Informative	23,638	$2.50	$59.02K	543,339
2025-09-02	Wong-sarad Grace	Principal Accounting Officer	Vente Informative	5,910	$2.50	$14.76K	103,448
2025-09-02	Berkley Neil Lindsay	Principal Financial Officer	Vente Informative	15,842	$2.50	$39.55K	346,570
2025-08-26	Hammond Paula	Director	Vente Informative	14,000	$2.36	$33K	74,909
2025-07-01	Rosenthal Arnon	Chief Executive Officer	Attribution de RSU	45,700	$1.42	$64.89K	45,700
2025-07-01	Kenkare-mitra Sara	President and Head of R&d	Attribution de RSU	18,250	$1.42	$25.92K	18,250
2025-07-01	Berkley Neil Lindsay	Principal Financial Officer	Attribution de RSU	18,000	$1.42	$25.56K	18,000
2025-06-20	Yaffe Kristine	Director	Vente Informative	1,000	$1.44	$1.44K	95,409
2025-06-20	Wong-sarad Grace	Principal Accounting Officer	Inconnu	11,552	$23.70	$273.78K	-
2025-06-20	Berkley Neil Lindsay	Principal Financial Officer	Inconnu	12,975	$1.11	$14.34K	-
2025-06-11	Desouza Errol B	Director	Attribution de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Lavigne Louis J Jr	Director	Attribution de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Scheller Richard H	Director	Attribution de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Altmeyer Mark	Director	Attribution de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Yaffe Kristine	Director	Attribution de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Hammond Paula	Director	Attribution de RSU	9,450	$1.63	$15.4K	9,450
2025-06-11	Garofalo Elizabeth A.	Director	Attribution de RSU	9,450	$1.63	$15.4K	9,450
2025-06-02	Grasso Marc	Chief Financial Officer	Vente Informative	16,488	$1.34	$22.07K	296,072
2025-06-02	Rosenthal Arnon	Chief Executive Officer	Vente Informative	52,087	$1.34	$69.71K	2,414,657
2025-06-02	Kenkare-mitra Sara	President and Head of R&d	Vente Informative	23,890	$1.34	$31.97K	512,252
2025-05-02	Scheller Richard H	Director	Attribution de RSU	15,833	-	-	66,666
2025-03-03	Grasso Marc	Chief Financial Officer	Vente Informative	18,091	$1.47	$26.55K	312,560
2025-03-03	Rosenthal Arnon	Chief Executive Officer	Vente Informative	40,330	$1.47	$59.18K	2,466,744
2025-03-03	Romano Gary	Chief Medical Officer	Vente Informative	16,306	$1.47	$23.93K	332,977
2025-03-03	Kenkare-mitra Sara	President and Head of R&d	Vente Informative	29,073	$1.47	$42.66K	536,142
2024-12-02	Grasso Marc	Chief Financial Officer	Vente Informative	16,489	$2.52	$41.54K	330,651
2024-12-02	Rosenthal Arnon	Chief Executive Officer	Vente Informative	52,172	$2.52	$131.44K	2,507,074
2024-12-02	Romano Gary	Chief Medical Officer	Vente Informative	14,892	$2.52	$37.52K	349,283
2024-12-02	Kenkare-mitra Sara	President and Head of R&d	Vente Informative	26,500	$2.52	$66.76K	565,215
2024-10-01	Grasso Marc	Chief Financial Officer	Attribution de RSU	216,400	-	-	347,140
2024-10-01	Rosenthal Arnon	Chief Executive Officer	Attribution de RSU	610,500	-	-	2,559,246
2024-10-01	Romano Gary	Chief Medical Officer	Attribution de RSU	184,380	-	-	364,175
2024-10-01	Kenkare-mitra Sara	President and Head of R&d	Attribution de RSU	300,000	-	-	591,715

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration